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Abstract Eosinophil peroxidase and myeloperoxidase play an
important role in the host defense. Both enzymes are present in
bone marrow, synthesized by blood progenitor cells. This
research investigated the kinetic properties of peroxidases under
immunostimulation in guinea pig bone marrow. Results suggest
that there are at least two myeloperoxidase isozymes and at least
three eosinophil peroxidase isozymes in guinea pig bone marrow
and that some of these isozymes are expressed upon immuno-
stimulation.
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1. Introduction
Two peroxidases (donor: hydrogen peroxide oxidoreduc-
tase, EC 1.2.1.7), eosinophil peroxidase (EPO) and neutrophil
peroxidase (myeloperoxidase: MPO) are present in bone mar-
row [1], synthesized by eosinophil and neutrophil cells. Eosi-
nophils, like neutrophils, are cytotoxic to mammalian tumor
cells and this cytotoxicity is mediated by a peroxidase (EPO or
MPO)-H2O2-halide system [2]. In contrast, human basophils
do not contain EPO [3]. Both MPO and EPO play an impor-
tant role as anti-infection agents. However, both enzymes may
also be detrimental and cause damage to host tissues like EPO
does in in£ammatory disease states [4,5] and MPO in some
leukemia [6]. EPO can also injure cells and tissues directly in
addition to its capacity to produce free radical species [7].
Because of the importance of EPO and MPO in the human
health and disease, both enzymes are now under intense in-
vestigation [6,8^11]. Both MPO and EPO have been puri¢ed
by various authors and their properties have been investigated
[12,13]. Furthermore, isozymes of peroxidase have been found
in plant [14,15] and MPO isozymes have been detected in
neutrophils [16]. Inactivation of peroxidases in bone marrow
by repeated administration of propylthiouracil has been re-
ported [17]. Moreover, quantitative assessments of hematopoi-
esis in experimental animals has shown both a decrease in the
cellularity of bone marrow after irradiation [18] or an increase
in that cellularity upon subcutaneous injection of granulocyte
colony stimulating factor [19,20]. Various methods for the
mobilization of peripheral blood progenitor cells into the cir-
culation have also been described [20,21]. But, to our knowl-
edge, stimulation of the peroxidases biosynthesis in bone mar-
row by an immunostimulant and their kinetic properties have
not yet been reported. Thus, the purpose of this research was
to investigate the kinetic properties of peroxidases in guinea
pig bone marrow under immunostimulation. Our results
showed that an increase in the granulocyte population was
accompanied by an increase in the activity of peroxidases
and the existence of multiple kinetically distinct MPO and
EPO in guinea pig bone marrow under immunostimulation.
A preliminary result of this research was published in [22].
2. Materials and methods
2.1. Chemicals
KCN, sodium azide, KI, cetyltrimethylammonium bromide
(CTAB) and Triton X-100 were from Sigma (St. Louis), all other
chemicals, including o-dianisidine, guaiacol and 3-amino-1H-1,2,4-tri-
azole (aminotriazole) were from Merck (Darmstadt, Germany) and all
were of the best grade available.
2.2. Immunostimulation
Immunostimulation was performed as follows: 1 ml sheep blood
was injected subcutaneously to 3^4 months old guinea pigs, daily, for
12 days. Injection of sheep blood was originally used by Winquist [23]
to induce basophilia in guinea pigs. However, we found that such an
injection produced also an increase in the number of eosinophils and
neutrophils.
2.3. Sample preparation
At various times ranging from 4 to 30 days after the ¢rst injection
of sheep blood, animals were killed by cervical dislocation after gen-
eral anesthesia. Front and hind legs were removed and bone marrow
smears were prepared and stained essentially according to [24]. Four
unstimulated animals were used as control. To remove and lyse the
red cells, the bone marrow was suspended in 150 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA and centrifuged at 800Ug. The pellet was
suspended in 9x NaCl and pelleted at 3000 rpm (1000Ug). The
pellet was frozen at 320‡C for up to 48 h. After two cycles of
freeze-thawing, cells were suspended in 50 mM Tris-HCl bu¡er (pH
7.4) containing 1 mM EDTA and 200 mg/l phenylmethylsulfonyl £u-
oride and homogenized with 20 passes in a Potter homogenizer (with
tight pestle). The homogenate was centrifuged at 20 000Ug for 15 min,
the pellet was discarded and the supernatant was used for the deter-
mination of peroxidase activity. The protein concentration was deter-
mined by the Biuret method.
2.4. Peroxidase activity
EPO activity was measured using two di¡erent substrates. (1)
Guaiacol oxidation was measured at 470 nm, using an extinction
coe⁄cient of 26.6 mM31/cm [25]. (2) KI oxidation was measured at
350 nm, using an extinction coe⁄cient of 26 mM31/cm [26]. MPO
activity was measured by following the o-dianisidine oxidation at
450 nm [27], using an extinction coe⁄cient of 11.3 mM31/cm [28].
In all cases, the reaction mixture consisted of 3 ml 0.1 M citrate
bu¡er, pH 5.0, 10 Wl sample, the appropriate substrate and H2O2 to
a ¢nal concentration of 0.33 mM. The ¢nal concentrations of sub-
strates were as follows: 33 mM for guaiacol, 5 mM for KI and 10 WM
for o-dianisidine. In some experiments, CTAB or Triton X-100 were
present at a ¢nal concentration of 0.05%.
All assays were carried out at room temperature (V22^25‡C) using
Aminco-DW2 and Milton-Roy spectrophotometers. Results were
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averages of two experiments (four controls and 2U6 animals). All
measurements were done in triplicate.
The velocity constant for the reaction between the enzyme-substrate
complex and the electron donor molecule, k4, was calculated accord-
ing to [25], as follows. Under our experimental conditions, given the
respective ¢nal concentrations of H2O2 and of substrate, k4 could be
expressed as follows:
k4  1=a0eUvx=vt
where vx/vt is the rate of substrate disappearance over the measured
time interval, a0 is the initial concentration of donor and e is the
concentration of enzyme (which was expressed as mg protein in the
sample).
3. Results and discussion
Fig. 1 shows variations in the absolute number of various
granulocytes in guinea pig bone marrow, at di¡erent times
after the onset of immunostimulation. The number of baso-
phil cells rose progressively with a 20-fold increase at day 12
after the ¢rst injection of sheep blood (from 0.5% at day 0 to
10.5% at day 12). Then, the basophils number dropped to
roughly the initial control value at day 16. The number of
eosinophil cells decreased up to day 4, then, increased pro-
gressively up to day 20. After that, the number of eosinophils
dropped again to reach the initial value at day 30. Thus, a 3-
fold increase in the number of eosinophil cells was seen at the
peak on day 20 (from 0.6U106 at day 0 to 1.6U106 at day
20). For neutrophil cells, after an initial decrease until day 4,
the number of cells rose progressively until day 12 and re-
mained at a plateau until day 20. It then decreased progres-
sively to reach approximately the initial value at day 30. Thus,
the results showed an increase in the total number of bone
marrow granulocytes under our stimulation conditions (Fig.
1, total granulocytes). This was similar to results obtained
upon subcutaneous injection of granulocyte colony stimulat-
ing factor [9,20]. The decrease seen on day 4 in the population
of eosinophils (from 0.6U106 at day 0 to 0.2U106 at day 4)
and neutrophils (from 2.1U106 at day 0 to 1.7U106 at day 4)
was due to their discharge in the blood circulation upon im-
munostimulation.
Fig. 2 shows the activity of bone marrow peroxidases at
di¡erent times after immunostimulation as measured by the
oxidation of o-dianisidine, guaiacol and KI. All substrates
showed roughly the same pattern of enzyme activity. With
o-dianisidine which is more sensitive to oxidation by MPO
[27], the peroxidase activity increased up to day 8, decreased
slightly at day 12, increased again at days 16 and 20 and
decreased at day 30. Thus, two peaks of peroxidase activity
at days 8 and 20 were seen and the maximum activity was
nearly 7-fold that of the control at day 0 (V80 nmol/s/mg
proteins for day 20 versus 12 nmol/s/mg proteins for day 0).
With guaiacol as substrate, however, the maximum increase in
activity at day 20 was over 30-fold the value of the control at
day 0 (V27 nmol/s/ mg proteins for day 20 versus 0.8 nmol/s/
mg proteins for day 0) while with KI as substrate, the max-
imum increase in activity at day 20 was about 4.5-fold the
control value (V29 nmol/s/mg proteins for day 20 versus
6.5 nmol/s/mg proteins for day 0). Since KI is a speci¢c sub-
strate for EPO [26], the increase in the rate of its oxidation
represents a true increase in the level of EPO by immunosti-
mulation. On the other hand, since guaiacol was reported to
be more sensitive than o-dianisidine to oxidation by EPO [27],
Fig. 1. Changes in granulocyte populations in bone marrow during
and after immunostimulation.
Fig. 2. Determination of peroxidase activity in bone marrow at vari-
ous times during and after immunostimulation. Activity was ex-
pressed as nmol substrate (o-dianisidine, guaiacol or KI) peroxidized
per s. Values were averages of two experiments (four controls and
2U6 animals). Measurements were done in triplicate.
Fig. 3. Variation of k4 values during and after immunostimulation
using o-dianisidine (A), guaiacol (B) or KI (C) as substrate.
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the di¡erential increase in the oxidation rate of guaiacol in-
dicated a preferential increase of EPO rather than MPO. In
the presence of 0.05% CTAB or 0.05% Triton X-100, the
activity of MPO and EPO was 30% higher than in the absence
of detergent. However, in order to remain as close as possible
to the in vivo situation, we did not base our kinetics studies
on detergent-stimulated peroxidases.
Table 1 shows the values of VMAX and KM obtained with o-
dianisidine. VMAX was lowest at day 12 (21 nmol/s/mg pro-
tein) and highest at day 20 (48 nmol/s/mg protein). KM was
lowest for the control at day 0 (4 WM) and highest at day 4 (19
WM). But a consistent pattern was not found, neither for
VMAX nor for KM. Similar results were found with KI and
guaiacol. As it was pointed out [29], there is no true VMAX for
peroxidase systems because the value depends upon the choice
of H2O2 concentration [29]. Thus, the values of VMAX and KM
obtained were not interpretable in terms of changes in the
amount or kinetic properties of peroxidases. In contrast, de-
termination of k4, as suggested in [29], might show a more
accurate picture of the changes in peroxidases under immu-
nostimulation. The reaction scheme was as follows:
EH2O2ÿ!k1 EOH2O
EO electron donorÿ!k4 EOÿ electron donor
Fig. 3 shows changes in the value of k4 under our exper-
imental conditions when o-dianisidine, guaiacol and KI were
respectively used as substrates. With o-dianisidine, k4 was
similar at days 0 (control) and 30, suggesting that the oxida-
tion of o-dianisidine was by the same kind of isozyme. In
contrast, under immunostimulation, another value of k4 was
observed for days 4^20, suggesting that another isozyme was
synthesized during that period. With guaiacol, k4 exhibited
roughly similar values for days 4, 8 and 12 and higher but
similar values for days 16, 20 and 30. With KI, the results
obtained paralleled those obtained with guaiacol, k4 exhibited
roughly similar values for days 4, 8 and 12 and higher but
similar values for days 16, 20 and 30. Since guaiacol and KI
are more sensitive than o-dianisidine to oxidation by EPO
[27], the k4 under our experimental conditions suggested the
existence of at least three EPO isozymes, one characterized by
the k4 value found for the control and the other two charac-
terized by the k4 values found for stimulated eosinophils. On
the other hand, o-dianisidine is more sensitive for the deter-
mination of MPO and showed possibly two isozymes with two
di¡erent k4s, one for control and for day 30, and one for all
others. The increases in peroxidase activity (Fig. 2) paralleled
the increase in the populations of both eosinophils and neu-
trophils (Fig. 1). On the fourth day after the onset of stim-
ulation, even though the populations of both types of gran-
ulocytes decreased, peroxidase activities increased. This might
be due to the appearance of young granulocytes exhibiting a
burst of peroxidase synthesis. Furthermore, it appeared that
the newly synthesized peroxidases were isozymes compared
with the unstimulated cells. From day 4 to 12, the isozymes
continued to be synthesized. Interestingly, after the last sub-
cutaneous injection of whole sheep blood cells on day 12, a
new isozyme was synthesized with an increased activity (Fig.
2).
The sensitivities to either MPO or EPO of the substrates
used are di¡erential rather than exclusive, although KI is al-
most exclusively oxidized by EPO [26]. Thus, results re£ected
oxidation by a mixture of enzymes with di¡erential activities.
However, results obtained in the presence of inhibitors helped
in the di¡erentiation between MPO and EPO. Substrate oxi-
dation was completely inhibited by 5 mM KCN or 100 WM
azide under all experimental conditions. 200 WM aminotria-
zole inhibited KI oxidation by 90% while it inhibited guaiacol
and o-dianisidine oxidation by 60 and 10%, respectively. It
has been well-established that EPO is highly sensitive to ami-
notriazole while MPO is not [30]. Thus, oxidation of KI rep-
resented the true value of EPO activity while guaiacol was
preferentially oxidized by EPO, assuming that the MPO and
EPO substrate speci¢cities were conserved in the isozymes.
Characterization of isozymes of EPO and MPO from bone
marrow necessitates large amounts of bone marrow cells
and tedious procedures of puri¢cation, electrophoresis and
ancillary methods. Thus, a prohibitive amount of time would
be required to purify and study MPO and EPO at various
times during immunostimulation (in this study, samples were
studied at seven di¡erent times during and after immuno-
stimulation). Furthermore, puri¢cation might also alter, e.g.
degrade, the protein and produce inaccurate kinetic proper-
ties. However, a kinetic approach like that described in this
work is a relatively simple procedure, reproducible, requiring
small amounts of material and it gave results consistent with
the presence of isozymes of peroxidase in plant [14,15] and
isozymes of myeloperoxidase in human neutrophils [16].
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